[Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 in vitro and in vivo.
Saved in:
| Title: | [Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 in vitro and in vivo. |
|---|---|
| Authors: | Zhang C; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Zhou SS; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Li XR; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Wang BM; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Lin NM; Laboratory of Clinical Pharmacy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China., Feng LY; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Zhang DY; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Zhang LH; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Wang UB; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China., Pan JP; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China. |
| Source: | Oncology reports [Oncol Rep] 2024 Oct; Vol. 52 (4). Date of Electronic Publication: 2024 Jul 26. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39054956 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: [Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 in vitro and in vivo. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhang+C%22">Zhang C</searchLink>; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China.<br /><searchLink fieldCode="AU" term="%22Zhou+SS%22">Zhou SS</searchLink>; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China.<br /><searchLink fieldCode="AU" term="%22Li+XR%22">Li XR</searchLink>; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China.<br /><searchLink fieldCode="AU" term="%22Wang+BM%22">Wang BM</searchLink>; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China.<br /><searchLink fieldCode="AU" term="%22Lin+NM%22">Lin NM</searchLink>; Laboratory of Clinical Pharmacy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.<br /><searchLink fieldCode="AU" term="%22Feng+LY%22">Feng LY</searchLink>; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China.<br /><searchLink fieldCode="AU" term="%22Zhang+DY%22">Zhang DY</searchLink>; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China.<br /><searchLink fieldCode="AU" term="%22Zhang+LH%22">Zhang LH</searchLink>; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China.<br /><searchLink fieldCode="AU" term="%22Wang+UB%22">Wang UB</searchLink>; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China.<br /><searchLink fieldCode="AU" term="%22Pan+JP%22">Pan JP</searchLink>; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229422756%22">Oncology reports</searchLink> [Oncol Rep] 2024 Oct; Vol. 52 (4). <i>Date of Electronic Publication: </i>2024 Jul 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22D%2EA%2E+Spandidos%22">D.A. Spandidos </searchLink><i>Country of Publication: </i>Greece <i>NLM ID: </i>9422756 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1791-2431 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221021335X%22">1021335X </searchLink><i>NLM ISO Abbreviation: </i>Oncol Rep <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39054956 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3892/or.2024.8783 Languages: – Code: eng Text: English Titles: – TitleFull: [Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 in vitro and in vivo. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang C – PersonEntity: Name: NameFull: Zhou SS – PersonEntity: Name: NameFull: Li XR – PersonEntity: Name: NameFull: Wang BM – PersonEntity: Name: NameFull: Lin NM – PersonEntity: Name: NameFull: Feng LY – PersonEntity: Name: NameFull: Zhang DY – PersonEntity: Name: NameFull: Zhang LH – PersonEntity: Name: NameFull: Wang UB – PersonEntity: Name: NameFull: Pan JP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2024 Oct Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1791-2431 Numbering: – Type: volume Value: 52 – Type: issue Value: 4 Titles: – TitleFull: Oncology reports Type: main |
| ResultId | 1 |
